COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
van Ewijk, Catharina E Kooijman, Marjolein N Fanoy, Ewout Raven, Stijn Fh Middeldorp, Marit Shah, Anita de Gier, Brechje de Melker, Hester E Hahné, Susan Jm Knol, Mirjam J
van Ewijk, Catharina E
Kooijman, Marjolein N
Fanoy, Ewout
Raven, Stijn Fh
Middeldorp, Marit
Shah, Anita
de Gier, Brechje
de Melker, Hester E
Hahné, Susan Jm
Knol, Mirjam J
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
Translated Title
Published in
Euro surveillance 2022;27(45):pii.2200217